Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia
about
Origin and therapy for hypertriglyceridaemia in type 2 diabetesComparison of therapeutic lipid target achievements among high-risk patients in Oman.Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease.
P2860
Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantification of concordance ...... betes and hypertriglyceridemia
@en
Quantification of concordance ...... etes and hypertriglyceridemia.
@nl
type
label
Quantification of concordance ...... betes and hypertriglyceridemia
@en
Quantification of concordance ...... etes and hypertriglyceridemia.
@nl
prefLabel
Quantification of concordance ...... betes and hypertriglyceridemia
@en
Quantification of concordance ...... etes and hypertriglyceridemia.
@nl
P2093
P2860
P1476
Quantification of concordance ...... betes and hypertriglyceridemia
@en
P2093
M J Abrahamson
P2860
P356
10.1016/J.DIABRES.2012.02.013
P577
2012-03-28T00:00:00Z